Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,064,442
-$49,563 QoQ
Shares Held
6,792
-6.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
#599
of 1,603 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CASTLEKEEP INVESTMENT ADVISORS LLC holds $2,159,814 across 2 Drug Manufacturers - General names. NVS ranks #2 (49.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,313 | $1,095,372 | |
| 2 | NVS |
Novartis AG
This page
|
6,792 | $1,064,442 |
All Filings in NVS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,064,442 | 6,792 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,114,005 | 7,293 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,044,227 | 7,574 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,016,045 | 7,923 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,344,663 | 11,112 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,334,527 | 11,971 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,127,725 | 11,589 | Shares | Sole | 2025-02-20 | |
| 2024-09-30 | $1,208,745 | 10,509 | Shares | Sole | 2025-02-21 | |
| 2024-06-30 | $1,070,029 | 10,051 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $974,941 | 10,079 | Shares | Sole | 2025-02-14 | |
| 2023-12-31 | $1,125,613 | 11,148 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||